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Polarizationof effectorCD4+Tcells canbe influenced
by both antigen-specific signals and by pathogen-
or adjuvant-induced cytokines, with current models
attributing a dominant role to the latter. Here we
have examined the relationship between these fac-
tors in shapingcell-mediated immunitybyusing intra-
vital imaging of CD4+ T cell interactionswith dendritic
cells (DCs) exposed to polarizing adjuvants. These
studies revealed a close correspondence between
strength of T cell receptor (TCR)-dependent signaling
and T helper 1 (Th1) versus Th2 cell fate, with antigen
concentration dominating over adjuvant in control-
ling T cell polarity. Consistent with this finding, at
a fixed antigen concentration, adjuvants inducing
Th1 cells operated by affecting DC costimulation
that amplified TCR signaling. TCR signal strength
controlled downstream cytokine receptor expres-
sion, linking the two components in a hierarchical
fashion. These data reveal how quantitative integra-
tion of antigen display and costimulation regulates
downstream checkpoints responsible for cytokine-
mediated control of effector differentiation.
INTRODUCTION
Antigen-activated naive CD4+ T helper (Th) lymphocytes can
differentiate into multiple distinct subsets, defined by expression
of surface markers, transcription factors, and effector cytokines.
Each subset plays an important and distinct role in mediating or
directing the nature of the host response induced upon exposure
to a pathogen, interaction with commensals, or vaccination. Past
studies have shown a central role for cytokines such as inter-
leukin-1 (IL-1), IL-2, IL-4, IL-6, IL-12, and IL-21, interferon-g
(IFN-g), or transforming growth factor-b (TGF-b) (Zhu and Paul,
2010) in dictating the differentiation path followed by an anti-
gen-engaged naive T cell. These findings have led to the widely
held view that activation of dendritic cells (DCs) by partic-
ular pathogen-associated molecular patterns (PAMPs) creates
a specific cytokine milieu, which in turn produces qualitatively
different intracellular responses that guide CD4+ T cell polar-
ization toward a specific effector phenotype (Medzhitov and
Janeway, 1997).Althoughmany of the reports linking cytokine milieu to effector
fate choice have been conducted with cells from TCR transgenic
animals and in vitro culture systems, a substantial body of in vivo
evidence also supports the key role played by cytokines in CD4+
T cell polarization (Zhu et al., 2010). Mice deficient in or overex-
pressing specific cytokines show dramatic changes in the nature
of the effector CD4+ T cells that emerge after immunization or
infection (Finkelman et al., 2004). Likewise, infection with partic-
ular organisms drives polarized effector CD4+ responses and
manipulation of the cytokine environment changes the character
and efficacy of these pathogen-driven responses (Sacks and
Noben-Trauth, 2002), providing in vivo support to a model in
which it is the qualitative effects of these soluble mediators
that play a dominant role in directing the nature of the cell-medi-
ated immune response.
Despite the widespread acceptance of this qualitative (cyto-
kine-defined) model, there are data showing that quantitative
factors, especially the strength of antigen stimulation through
the TCR, make important contributions to T cell polarity choice.
Both in vitro and in vivo studies (Constant et al., 1995; Hosken
et al., 1995; Milner et al., 2010; Yamane et al., 2005) have
demonstrated that the extent of signaling through the TCR and
associated costimulatory receptors can dictate the outcome
of differentiation. A high dose of peptide or a strongly agonistic
ligand favorsdevelopmentofTh1 (IFN-g-producing) cellswhereas
stimulationwith a low dose of peptide or a weakly agonistic ligand
favors Th2 (IL-4-, IL-5-, and IL-13-producing) cells.
Because most studies evaluating the role of cytokines in vitro
are done at single antigen or anti-TCR antibody concentrations,
the quantitative component is generally removed from consider-
ation, giving the appearance that cytokines dominate. In vivo, in-
fections provide a particular degree of antigenic stimulation that
is not usually subject to experimental manipulation, making it
difficult to parse out the role of signaling strength in experiments
that alter the cytokine environment in infected animals. Given
that variations in both the cytokine milieu and extent of TCR
signaling exist in vivo during infections or upon vaccination, we
felt that it was important to ask how the cell interprets such com-
plex stimuli and specifically whether one category of inputs is
hierarchically dominant. To this end, we devised amodel system
in which both the cytokine milieu and the strength of antigen
stimulation could be independently varied to explore how
quantitative and qualitative aspects of signaling regulate CD4+
T cell differentiation. Dynamic 2-photon microscopy (2P-IVM)
was used to directly assess T cell-DC interaction duration, syn-
apse size, and calcium signaling. By varying both the adjuvant
exposure used to activate DCs and control their cytokineImmunity 41, 63–74, July 17, 2014 ª2014 Elsevier Inc. 63
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Figure 1. Exposure of DCs to Polarizing Adjuvants Alters the Balance of CD4+ T Cell Effector Fates in Concert with Changes in Cellular
Interaction Times
(A–C, F–H) Assessment of 5CC7 cell differentiation after priming with (A–C) LPS- versus papain-treated DCs or (F–H) CpG- versus SEA-treated DCs at day 4
postadoptive transfer. Data are representative of three experiments (n = 4).
(D and I) Individual cellular interaction times of polyclonal or 5CC7 T cells interacting with adjuvant-treated DCs, 0–2 hr posttransfer as determined after 2P-IVM
imaging. Data are pooled from five (D) or three (I) animals.
(E and J) Mean cellular interaction times for separate 2P-IVM experiments. Data represent the mean interaction times from five (E) or three (J) animals.
Error bars represent mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001 as determined by (B–E, G, H) 1-way ANOVA with Tukey’s posttesting or (I, J) Student’s t test.
Immunity
TCR Signals Control In Vivo T Cell Polarizationproduction and costimulatory capacity, as well as by carefully
modulating the peptide-MHC class II (pMHC) ligand display
encountered by the responding T cells, we obtained direct infor-
mation about how these distinct factors influenced strength of
signaling in vivo. Through this crossover experimental design,
imaging-based measurements, and assessment of postprim-
ing effector T cell phenotype, we found that strength of signal
dominates over adjuvant and cytokines in dictating Th1 versus
Th2 cell fate. Adjuvants influenced polarization through the
effects of costimulation on TCR signaling, with the strength of
the combined TCR and costimulatory stimulus in turn controlling
cytokine receptor expression. These findings reveal that anti-
gen-dependent events act as upstream regulators of secondary
checkpoints leading to the type of cytokine control typically
given priority in models of T cell differentiation.
RESULTS
CD4+ T Cells Undergoing Th1 as Compared to Th2 Cell
Polarization Show Greater T Cell-DC Interaction Times
We began our studies by examining the ability of adjuvant treat-
ment of DCs to promote Th1 versus Th2 effector cell develop-
ment at a fixed moderate concentration of available TCR ligand.
DCs were pulsed with 0.1 mM pigeon cytochrome C peptide
(pPCC) in the presence of either lipopolysaccharide (LPS)
(LPS-DC) or papain (papain-DC) and the DCs were adoptively
transferred into CD45.1+ B10.A animals. After 18 hr, naive
antigen-specific 5CC7 TCR transgenic CD45.2+CD4+ T cells
specific for pPCC were transferred into the same animals. Four
days later, Th1 versus Th2 cell differentiation was assessed by
measuring IFN-g or IL-4 production, respectively, by restimu-
lated recovered 5CC7 cells. LPS-treated DCs induced a strongly
biased Th1 cell response, whereas interaction with papain-
treated DCs led to a Th2 cell skewed response (Figures 1A–
1C). We did not detect cells producing IL-17 under these condi-64 Immunity 41, 63–74, July 17, 2014 ª2014 Elsevier Inc.tions (data not shown) and note that the fraction of cells showing
either a Th1 or Th2 cell effector state is in accordwith other in vivo
immunization findings (Leo´n et al., 2012; Tokoyoda et al., 2009;
van Panhuys et al., 2008).
To determine whether adjuvant treatment altered in vivo traf-
ficking or the uptake and display of ligand by these cells, thus
affecting the intensity of the TCR signaling, DCs were pulsed
with long chain biotinylated-pPCC (LC-pPCC) in the presence
of LPS or papain and LC-pPCC binding to MHCII was assessed.
Both LPS-DC and papain-DC displayed similar MHCII and LC-
pPCC staining (Figures S1A–S1G available online). In addition,
similar numbers of adjuvant-treated DCs accumulated in the
draining LN (dLN), showing that the adjuvant pretreatment did
not alter the migratory capacity of DCs (Figure S1H), and no sig-
nificant difference was detected in MHCII or LC-pPCC staining
on DCs recovered from the dLN (Figures S1I–S1L), indicating
equivalent antigen presentation in vivo.
Although these data suggested that adjuvants did not have a
direct effect on quantitative aspects of T cell activation via modi-
fication of ligand display, a possible effect on overall strength
of TCR signaling was possible. To explore this issue in vivo,
2P-IVM was employed. The duration of T cell-DC interactions
was measured and the effect of adjuvants evaluated in the
context of previously defined sequential stages of T cell-DC
interaction (Mempel et al., 2004) in which phase transition has
been linked to the strength of TCR-related signaling (Henrickson
et al., 2008). DCswere fluorescently labeled after incubation with
pPCC and LPS or papain and adoptively transferred. After 18 hr,
5CC7 CD4+ T cells and wild-type (WT) polyclonal CD4+ T cells
labeled with distinct fluorophores were transferred and cellular
interactions in the dLN immediately imaged (Movie S1). Because
previous work has indicated that adjuvants induce differential
chemokine production from DCs (Tang et al., 2010), we sought
to determine whether adjuvant pretreatment would lead to pref-
erential interaction of 5CC7 cells with LPS- or papain-treated
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Figure 2. Exposure of DCs to Polarizing Adjuvants Alters Phase 2 and Phase 3 Interactions
(A and B) Distribution of interaction times of polyclonal and 5CC7 cells with pPCC-loaded papain- or LPS-treated DCs at (A) 12 hr and (B) 22 hr posttransfer.
(C and D) Mean experimental interaction times at (C) 12 hr and (D) 22 hr posttransfer.
(E and F) Mean experimental velocities at (E) 12 hr and (F) 22 hr posttransfer.
(G) Percentage of 5CC7 cell:DC conjugates originally observed still remaining over time. Imaging was conducted for 1 hr.
(A, B, and G) Pooled data from four experiments.
(C–F) Mean ± SEM of data from four experiments.
*p < 0.05, **p < 0.01, and ***p < 0.001 as determined by 1-way ANOVA with Tukey’s posttesting.
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and papain-treated DCs at similar rates, indicating that a differ-
ential chemoattractant potential was not conferred on the DCs
by the distinct adjuvant pretreatments (Figures S2A–S2C). Poly-
clonal cells interacting with either LPS-DCs or papain-DCs ex-
hibited brief browsing behavior as previously reported (Miller
et al., 2004), whereas antigen-specific 5CC7 cells exhibited
more prolonged interactions with the antigen-bearing DCs (Fig-
ures 1D and 1E). A proportion of the 5CC7 contacts involving
LPS-treated DCs rapidly transitioned to phase 2-like interac-
tions, with contacts lasting >1 hr (Mempel et al., 2004). In
contrast, prolonged interactions characteristic of phase 2-like
behavior were virtually absent among 5CC7 cells interacting
with papain-DCs.
To assess whether such interaction differences were generally
associated with adjuvant effects promoting Th1 versus Th2 cell
development at the same TCR ligand density, we compared
DCs treated with the Th1-cell-inducing adjuvant CpG oligodeox-
ynucleotides (CpG) with those treated with the Th2-cell-inducing
adjuvant Schistosomal egg antigen (SEA) (Figures 1F–1H). Pre-
treatment of DCs with distinct adjuvants did not alter the chemo-
ttractive potential of DCs; the 5CC7 cells showed equal rates of
contact with SEA-treated versus CpG-treated DCs (Figures
S2D–S2F). As seen for the other adjuvant set, DCs exposed
to the Th1-cell-promoting adjuvant showed significantly longer
interaction times with 5CC7 cells and a more rapid transition
to phase 2-like behavior as compared to DCs exposed to the
Th2-cell-inducing adjuvant (Figures 1I and 1J). These data with
two distinct adjuvant pairs, taken in the context of previous
studies showing that more rapid transition to phase 2 behavioris related to increased TCR signaling (Henrickson et al., 2008),
suggest a potential quantitative effect of adjuvant treatment on
the TCR-associated signaling capacity of DCs displaying equal
concentrations of antigen.
To determinewhether adjuvant treatment affected cell interac-
tion dynamics at later time points, also suggesting differences in
TCR-associated signaling, we imaged the cohort of 5CC7 cells
recruited to the LN 0–2 hr after transfer by blocking further
recruitment with anti-CD62L (Mempel et al., 2004). At 12 hr post-
transfer, a significant proportion of 5CC7 cells interacted stably
with LPS-DCs for the majority of the imaging time, whereas only
a small proportion of 5CC7 cells interacting with papain-DCs did
so (Figures 2A, 2C, 2E, 2G, S3A, and S3B; Movie S2). At 22 hr af-
ter transfer, the majority of 5CC7 cells interacting with papain-
DCs showed phase 3 behavior, exhibiting increased migration
speeds and a mean interaction time similar to that of polyclonal
cells (Figures 2B, 2D, and 2F; Movie S2). In contrast, many long-
term interactions were still evident between 5CC7 cells and
LPS-DCs (Figures 2B and 2G). Together, these results indicate
that incubation of DCs with a Th1-cell-inducing adjuvant leads
to stable long-lived interactions with antigen-specific T cells,
whereas DCs exposed to a Th2-cell-inducing adjuvant show
few prolonged interactions with specific T cells and the lympho-
cytes rapidly progress to phase 3 dynamic behavior.
To further determine whether qualitative mediators such
as chemokines or cytokines released by DCs into the local
milieu contribute to the differences in interaction times that we
observed, antigen-loaded adjuvant-stimulated LPS-DCs and
papain-DCs were labeled with distinct dyes and cotransferred
into the same recipient. At 18 hr posttransfer, labeled naiveImmunity 41, 63–74, July 17, 2014 ª2014 Elsevier Inc. 65
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Figure 3. Different Adjuvant Treatments of DCs Alter Contact
Duration but Not Initial Contact Frequency with CD4+ T Cells
pPCC-loaded papain- and LPS-stimulated DCs were alternately labeled and
cotransferred into naive B10.A hosts. At 18 hr posttransfer, 5CC7 cells were
adoptively transferred and imaged for 2 hr.
(A) 5CC7 and DC cell numbers per LN were determined postimaging.
(B) Ratio of LPS-treated:papain-treated DCs per LN.
(C and D) Mean number of CD4+ T cell interactions per DC (C) and frequency
distribution of interactions (D).
(E) Interaction times of 5CC7 CD4+ T cells with DCs.
(F) Ratio of 5CC7 cells interacting with LPS-DC:papain-DC after 2 hr.
Data are indicative of five LNs. Means ± SEM. *p < 0.05, **p < 0.01, and
***p < 0.001 as determined by Student’s t test.
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cellular interactions were imaged (Movie S3). LPS-DCs and
papain-DCs both reached the dLN in equal numbers and
showed similar initial rates of interaction with 5CC7 cells (Figures
3A–3D). In these mixed transfer conditions, 5CC7 cells ex-
hibited significantly greater interaction times with LPS-DCs as
compared to papain-DCs (Figure 3E) and the transferred
T cells were found to be preferentially associated with LPS-
DCs after 2 hr of imaging (Figure 3F). These data argue that the
distinct interaction durations seen with DCs exposed to different
adjuvants occur as a result of cis-regulated interactions between
T cells and antigen-bearing DCs and are not due to the chemo-
kine or cytokine milieu created by the adjuvant-treated DCs.
Th1-Cell-Inducing Adjuvants Promote Stronger Ca2+
Signaling and Larger Synapse Size among Interacting
CD4+ T Cells
The preceding dynamic imaging studies suggested that adjuvant
exposure of DCs alters a T cell’s quantitative perception of66 Immunity 41, 63–74, July 17, 2014 ª2014 Elsevier Inc.antigen load. To explore this idea further, we used 2P-IVM to
examine Ca2+ flux (Figures 4A and 4B; Movie S4), which reflects
the strength of ligand-induced TCR signaling and is associated
with the arrest of migratory behavior (Bhakta et al., 2005). Cells
were characterized as ‘‘noninteracting’’ where no DC contact
was observed, ‘‘briefly interacting’’ where contact was made
without a decrease in cellular velocity (Movie S4), and ‘‘interact-
ing’’ where contact was made and cellular velocity decreased to
<2 mm/min; Ca2+ flux over time was recorded for each of these
types of events (Figures 4C, 4D, 4G, and 4H; Movie S4). Mean
Ca2+ flux (Figures 4E and 4I), the area under the Ca2+ trace
(Figures 4F and 4J), and peak Ca2+ flux (Figure S4A) were then
determined for the imaged T cells. For all conditions, we saw
no significant difference in Ca2+ flux for 5CC7 cells classified
as noninteracting or briefly interacting. However, among 5CC7
cells that formed stable interactions, DCs cultured with
Th1-cell-inducing adjuvants induced a significantly higher Ca2+
response. There was a clear positive correlation between extent
of the Ca2+ flux evoked by the interaction of T cells with the
adjuvant-treated DCs (LPS-DCs [Figures S4B–S4D] and
papain-DCs [Figures S4E–S4G]) and the resulting interaction
time of the cells, consistent with the previous interpretation of
the phase transition data as indicating a difference in proximal
TCR signaling by 5CC7 cells contacting DCs exposed to distinct
adjuvants despite equivalent peptide loading.
As a further measure of TCR-dependent interactions, we
analyzed the dimensions of the T cell-DC interface (immunolog-
ical synapse) (Klauschen et al., 2009). At 2 hr posttransfer,
LNs were fixed, serially sectioned, and imaged, and whole LNs
were digitally reconstructed (Figure S4H; Movie S5). From these
images, DC-T cell interaction interfaces were determined (Fig-
ure S4I; Movie S5). LPS-DCs showed a significantly larger
cellular interface with 5CC7 cells as compared to papain-DCs
(Figures 4K and 4L), consistent with the stronger Ca2+ signaling
and longer duration interactions observed with LPS-DCs. In
sum, these data supported a per DC cis-effect of adjuvant
on the strength of TCR-associated signaling at a given pMHC
density.
Modulation of TCR-Dependent Signal Strength Alters
T Cell Polarization Outcome and Overrides Adjuvant
Effects
The observations described above revealed that Th1- and Th2-
cell-polarizing adjuvants influenced the strength and duration
of early antigen-induced signals in a manner correlating with
past evidence that strong signaling promotes Th1 cell responses
whereas weaker stimulation favors Th2 cell development. How-
ever, it remained unclear whether these quantitative differences
causally determined T cell fate or were simple correlations, with
qualitative signals from cytokines induced by adjuvants having
a more important role in guiding differentiation. Therefore, we
examined whether manipulating the strength of signal by varying
the concentration of peptide used to pulse DCs would override
putative dominant qualitative cytokine signaling mechanisms
induced by adjuvant treatment. DCs were pulsed with a range
of peptide concentrations (10.0–0.01 mM) in the presence of
either LPS or papain and used to prime 5CC7 cells in vivo. After
priming with the DCs exposed to different peptide concentra-
tions, dLNs were collected and the relative Th1 versus Th2 cell
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Figure 4. Greater Ca2+ Signaling and Synapse Size of CD4+ T Cells
Interacting with DCs Exposed to Th1- versus Th2-Cell-Promoting
Adjuvants
(A–J) DCs were loaded with pPCC and treated with either (A–F) LPS or papain
or (G–J) CpG or SEA and transferred into naive B10.A hosts. At 18 hr post-
transfer, 5CC7 cells loaded with CMTPX and Fluor-4 were adoptively trans-
ferred and imaged for 2 hr.
(A) Representative micrograph of 5CC7 cell tracking during Ca2+ flux analysis
by 2P-IVM.
(B) 5CC7 cell tracks were analyzed after 2P-IVM, and normalized Ca2+ flux
(blue) and instantaneous velocity (red) were used to characterize interactions.
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qualitative model would predict that changing pPCC amounts on
adjuvant-treated DCs should result in the same bias of Th cell
polarization but with more or fewer cells adopting the expected
fate, whereas a quantitative model involving TCR-dominated
signaling would predict a change in Th cell fate outcome as pep-
tide concentration was altered.
To assess whether variable loading with synthetic peptides
had any effect on the DCs other than in terms of pMHC display,
we examined the surface activation phenotype of these cells as
well as their production of IL-6, IL-10, and IL-12 (Figures S5A–
S5D). These variousmeasures should sensitively report the pres-
ence of PAMPs in the peptide preparations that might influence
how the DCs behave in vivo. We found no significant differences
in these various measures after peptide treatment, providing
strong evidence that any changes in T cell fate influenced by
varying the peptide loading of the DCs reflect the influence of
pMHC density.
After activation with DCs pulsed with 10.0 mM pPCC, a Th1-
cell-biased response predominated even after DC treatment
with the Th2-cell-evoking adjuvant papain (Figures 5A–5C).
However, as the concentration of pPCC was decreased, the
proportion and numbers of IL-4-producing cells increased coin-
cident with a decrease in IFN-g-producing cells, such that at
0.01 mM pPCC, a Th2 cell response was predominantly evoked
regardless of the adjuvant used to treat the DCs (Figures 5D
and S5A). These findings suggest that the strength of proximal
signaling induced in the T cell by the DC dominates over any
qualitative effects imparted by adjuvants. Consistent with this,
5CC7 cells showed significantly decreased interaction times
andCa2+ fluxes (Figures 5E–5H and S5B–S5D) when recognizing
LPS-DCs pulsed with a low concentration of pPCC (Lo-LPS:
0.01 mM) as compared with papain-DCs pulsed with high con-
centrations of pPCC (Hi-pap: 10.0 mM). Thus, the degree of early
proximal T cell signaling was more tightly correlated with Th cell
differentiation outcome than was the adjuvant used to treat the
DCs and quantitative features of T cell-DC interactions appeared
to be dominant over qualitative signals arising from adjuvant
exposure of the DCs.
Adjuvants Influence Signal Strength through Effects
on Costimulatory Molecule Expression
To probe how elevated proximal TCR-related signaling could
occur using LPS- or CpG-treated DCs presenting similar
amounts of pMHC TCR ligand in comparison to papain- or
SEA-treated DCs, we extended our phenotypic analysis of DCs
in vitro and ex vivo. There were no significant differences
between the DC treatment groups in terms of physical(C, D, G, and H) Individual 5CC7 cell Ca2+ flux tracings for cells interacting with
adjuvant-treated (LPS in C; papain in D; CpG in G; SEA in H) DCs are shown for
durations of T cell:DC contacts classified as involving no interaction (blue),
brief interactions (green), or stable interactions (red).
(E, F, I, and J) Mean Ca2+ flux (E and I) and integrated Ca2+ flux areas (F and J)
were calculated for individual cell tracks.
(K and L) Distribution of 5CC7 cell:DC interaction interface sizes (K) and
experimental mean interaction interface sizes (L).
Shown are five pooled experiments (E, F, K), three pooled experiments (I and
J), andmeans from five separate experiments (L). Mean ± SEM. *p < 0.05, **p <
0.01, ***p < 0.001 as determined by 1-way ANOVA with Tukey’s posttesting.
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Figure 5. The Magnitude of Antigen-Dependent Signal Strength Dominates over Qualitative Effects of Adjuvants on DCs
(A) Assessment of 5CC7 cell differentiation after priming with LPS- or papain-treated DCs loaded with 10–0.01 mM pPCC, at day 4 after adoptive transfer.
(B) Quantification of percent of 5CC7 cells expressing IL-4 or IFN-g.
(C) Number of 5CC7 cells expressing IL-4 or IFN-g.
(D) Ratio of %IFN-g:%IL-4 producers.
(E) Cellular interaction times 0–1 hr posttransfer of 5CC7 cells with Lo-LPS- or Hi-papain-treated DCs.
(F) Mean interaction times for individual experiments.
(G) Integrated Ca2+ flux areas were calculated for individual cellular tracks.
(H) Mean integrated Ca2+ flux areas for individual experiments.
Data are representative of four experiments (n = 4) (A–D), pooled from four experiments (E and G), or representative of four experiments (F and H). Mean ± SEM.
*p < 0.05, **p < 0.01, and ***p < 0.001. 1-way ANOVA with Tukey’s posttesting.
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molecule-1 (ICAM-1), and inducible costimulatory molecule
ligand (ICOSL) or presentation of LC-pPCC (Figures 6A, 6C,
and S6A–S6F). One major difference that correlated with
outcome did emerge, however; DCs treated with Th1-cell-
inducing adjuvants had higher expression of the CD28 ligands
CD80 and CD86 than did those exposed to Th2-cell-inducing
adjuvants (Figures 6B, S6E, and S6F). CD80 signaling can poten-
tiate Ca2+ flux upon TCR activation (Nurieva et al., 2007) and
mediate tighter T cell-DC interactions (Lim et al., 2012), poten-
tially explaining the increased TCR-associated signaling
observed after treatment of DCs with Th1 cells as compared68 Immunity 41, 63–74, July 17, 2014 ª2014 Elsevier Inc.with Th2-cell-inducing adjuvants at a constant pMHC density.
To assess this possibility, we utilized antibody blockade of
CD80 signaling during in vivo activation of 5CC7 cells with
LPS-DCs or papain-DCs. Although affecting only one of several
costimulatory ligands on the DCs upregulated by LPS treatment,
antibody treatment led to a significant decrease in IFN-g produc-
tion and a corresponding increase in IL-4 production by the
recovered 5CC7 cells (Figures 6D and 6E). 2P-IVM imaging
showed that treatment with aCD80 resulted in a decrease both
in T cell interaction timeswith the LPS-DCs and in the associated
T cell Ca2+ flux (Figures 6F–6I), yielding a pattern more similar
to that observed under Th2-cell-inducing conditions. These
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Figure 6. T Cell Interpretation of Antigen Display Is Affected byCD80
Costimulation
pPCC-loaded LPS- or papain-treated DCs were isolated from dLN at 24 hr
posttransfer and analyzed.
(A–C) MHCII (A), CD80 (B), and PCC peptide (C) presentation reported as MFI
poststaining.
(D and E) Percent of 5CC7 cells producing IL-4 (D) and IFN-g (E) at day 4 after
adoptive transfer, after priming with LPS- or papain-treated DCs, with or
without blocking with anti-CD80.
(F) Cellular interaction times 0–2 hr posttransfer of 5CC7 cells treated with LPS
or papain.
(G) Mean interaction times for individual 2P-IVM experiments.
(H and I) Mean Ca2+ flux values (H) and integrated Ca2+ flux areas (I) were
calculated for individual cellular tracks.
Data are representative of two experiments (n = 4) (A–C), representative of
three experiments (n = 4) (D and E), pooled from three experiments (F, I, J),
or representative of three experiments (G). Error bars indicate mean ± SEM.
*p < 0.05, **p < 0.01, and ***p < 0.001, as determined by 1-way ANOVA with
Tukey’s posttesting (A–E, H, I) or Student’s t test (F, G).
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DCs exposed to distinct adjuvants even when peptide-MHC
display is equalized and indicate that adjuvants can influence
T cell polarization through dominant effects on proximal strength
of signal involving TCR cooperation with CD28.
TCR-Associated Signal Strength Regulates
Downstream Cytokine Signaling Checkpoints
To reconcile our results with previous data showing a crucial role
for adjuvant-elicited cytokines in directing effector T cell devel-
opment, we theorized that TCR signaling may operate upstream
of cytokine-mediated checkpoints; that is, signal strength con-
trols T cell responsiveness to polarizing cytokines, which would
then drive the molecular events involved in differentiation.
IL-12p70 is a critical myeloid-cell-derived cytokine involved in
Th1 cell polarization (Zhu et al., 2010), which has been shown
to be delivered via the immunological synapse (Pulecio et al.,
2010). The complete IL-12 receptor is not expressed on naive
CD4+ T cells (Desai et al., 1992), so we tested whether upregula-
tion of the relevant IL-12Rb2 chain was associated with DC
signal strength and the length of interaction with the antigen-
bearing DCs. DCs were pulsed with varying concentrations of
pPCC and used to activate 5CC7 cells in vitro. After activation,
increased IL-12Rb2 expression was found to correlate directly
with the concentration of pPCC presented (Figure 7A). Activation
was required for the induction of IL-12Rb2 expression and both
the frequency of positive cells and mean fluorescent intensity
(MFI) of IL-12Rb2 expression showed a direct correlation with
the dose of antigenic peptide (Figures 7B and 7C).
Because our in vivo results indicated that Th1 cell develop-
ment was associated with long-term T cell-DC interactions, we
examined whether there was also a temporal component to
the upregulation of IL-12Rb2. IL-12Rb2 expression was induced
only after >6 hr in culture with high concentrations of pPCC (Fig-
ure 7D). To determine whether polarizing cytokines materially
affected IL-12Rb2 expression, we compared normal 5CC7 cells
with Il4/Ifng/ 5CC7 cells and found that there was no alter-
ation in IL-12Rb2 expression in the absence of these key medi-
ators (Figure 7D). To investigate the physiological significance
of these in vitro findings, we again used antigen-loaded, adju-
vant-exposed DCs to activate naive 5CC7 cells in vivo. After
in vivo activation, CD4+ T cell interaction with LPS-DCs resulted
in higher IL-12Rb2 expression in comparison to T cell exposure
to papain-DCs (Figures 7E and S7A–S7D). Additionally, 5CC7
cells activated by LPS-DCs had increased amounts of the phos-
phorylated transcription factor STAT4 in comparison to those
activated by papain-DCs (Figures 7F and 7G). Together, these
findings indicate that the strength of antigen-dependent signals,
as influenced by pMHC concentration and costimulation and
the corresponding duration of T cell-DC interactions, control
downstream cytokine response checkpoints that ultimately
direct effector polarization.
DISCUSSION
The differentiation of naive CD4+ T cells into distinct effector
subsets plays a major role in governing the outcome of the
adaptive immune response. Both qualitative characteristics of
the cytokine milieu and quantitative signals imparted throughImmunity 41, 63–74, July 17, 2014 ª2014 Elsevier Inc. 69
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Figure 7. Signal Strength Determines the
Ability of CD4+ T Cells to Respond to Polar-
izing Cytokines
5CC7 cells were activated in vitro using P13.9
artificial antigen-presenting cells preincubated
with the concentrations of pPCC indicated. At
24 hr postactivation, IL-12Rb2 expression by the
T cells was determined by flow cytometry.
(A) Representative plots of IL-12Rb2 expression by
stimulated (black lines) or naive (gray lines) 5CC7
cells.
(B) Percent of activated (CD69+) and nonactivated
(CD69) 5CC7 cells expressing IL-12Rb2.
(C) Comparison of IL-12Rb2 MFI for activated
versus nonactivated 5CC7 cells.
(D) WT 5CC7 or 5CC7 Il4/Ifng/ (2ko) cells were
stimulated in vitro with P13.9 cells preincubated
with either 0.01 mM or 10 mM pPCC and IL-12Rb2
expression determined.
(E–G) 5CC7 cells were activated in vivo with LPS-
or papain-treated DCs and compared to control
5CC7 cells from non-dLNs. Ex vivo expression of
IL-12Rb2 (E) and pSTAT4 (F and G) by CD69+
5CC7 CD4+ T cells was then determined at 24 hr
posttransfer.
Data are representative of two experiments (n = 4)
(A–C) or representative of three experiments (n = 4)
(D–G). Means are plotted ±SEM. *p < 0.05, **p <
0.01, and ***p < 0.001 as determined by 1-way
ANOVA with Tukey’s posttesting.
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specific T helper subsets (Yamane and Paul, 2013). Our data
demonstrate that the differentiation of naive CD4+ T cells into
Th1 or Th2 cell effectors involves a series of checkpoints that
begins with a quantitative T cell assessment of antigen and cos-
timulatory signals, which in turn secondarily control the respon-
siveness of the T cell to polarizing cytokines. Weak signals are
sufficient to activate CD4+ T cells and induce Th2 cell differentia-
tion after brief interactions, potentially through an endogenous
Th2-cell-differentiation program (Zhu et al., 2012). Conversely,
Th1 cell differentiation requires strong signaling and a transition
to long-term interactions. Integration of strong signals induces
a divergent program of early activation gene expression,70 Immunity 41, 63–74, July 17, 2014 ª2014 Elsevier Inc.including upregulation of IL-12Rb2, which
allows further tuning of the immune
response by the cytokine environment.
Taken as a whole, these findings reveal
how adjuvants not only alter the ability of
APCs to produce qualitative signals
(Medzhitov and Janeway, 1997) affecting
CD4+ T cell differentiation, but play a crit-
ical and indeed dominant role in the latter
process through effects on costimula-
tory molecule expression that synergizes
with antigen to control signals associated
with TCR engagement.
This relationship between signal
strength and effector fate can be
observed in animals with a polyclonal
T cell repertoire and absent artificiallyapplied adjuvants, arguing against the present findings being
unique to the experimental system we employed. Consistent
with our findings showing that low signal strength promotes
Th2 cell induction, expression of hypomorphic variants of the
TCR-proximal signaling adaptor LAT leads to spontaneous in-
duction of Th2-cell-associated autoimmunity (Mingueneau
et al., 2009). Likewise, ZAP70mrd/mrt animals exhibit defective
T cell Ca2+ mobilization along with elevated IgG1 and IgE, iso-
types characteristic of a Th2 cell response (Siggs et al., 2007).
Proteins further downstream in the signaling cascade such as
PKCq and Wiskott Aldrich Syndrome protein (WASp) play
opposing roles in the maintenance of the IS (Sims et al., 2007),
with PKCq contributing to termination of stable synaptic
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TCR Signals Control In Vivo T Cell Polarizationinteraction with DCs and WASp acting as a negative regulator of
the PKCq-mediated symmetry breaking process. In accordance
with our data indicating the importance of a temporal element in
CD4+ T cell differentiation, activation conditions favoring PKCq
signaling and shorter interactions preferentially induce Th2 cell
differentiation (Cannons et al., 2004; Corn et al., 2005; Hilliard
et al., 2002; Marsland et al., 2004; Medoff et al., 2006), whereas
those that enhance IS stabilization and Ca2+ signaling result in
preferential Th1 cell differentiation (Noble et al., 2000). Further,
defects in WASp are associated with reduced Th1 cell differen-
tiation (Taylor et al., 2010; Trifari et al., 2006) and development
of Th2-cell-associated autoimmune disease (Ozcan et al.,
2008) and molecules associated with enhanced Ca2+ signaling
and IS formation are required for efficient Th1 cell differentiation
or the suppression of spontaneous Th2-cell-associated disease
(Oh-Hora et al., 2008; Tahvanainen et al., 2009; Varga et al.,
2010).
Studies of the TCR itself provide further evidence for a primary
role of signal strength in controlling T cell fate. Single naive poly-
clonal CD4+ T cells can produce an array of effector cells and the
pattern of effector cells generated after in vivo activation with
cognate antigen correlated with the TCR-pMHCII dwell time or
the amount of pMHCII (Tubo et al., 2013). Depletion of CD4+
T cells with a high affinity for pMHCII from a polyclonal popula-
tion of cells left lower-affinity T cells that preferentially differenti-
ated into IL-4-producing Th2 cells (Milner et al., 2010). Single cell
cloning showed that low-affinity cells had fewer preferred
complementarity determining region-3 (CDR3) motifs, consis-
tent with findings that the outgrowth of CD4+ T cells under Th2
cell conditions favored cells with elongated TCRa CDR3 motifs
that potentially impeded TCR triggering (Boyton et al., 2002).
Finally, two strains of transgenic mice created with two different
TCRs specific for the same self-antigen (gastric ATPase) show
biased Th1- versus Th2-cell-associated disease associated
with differences in availability of self-antigen-MHC class II
ligands rather than intrinsic affinity for the ligands (Levin et al.,
2008). Our present analysis that emphasizes the dominant and
upstream role of antigen-dependent strength of signaling in
controlling effector polarization provides a coherent, integrated
explanation for these many distinct observations.
Although our data and these cited studies provide a consis-
tent picture of regulation of Th1-Th2 cell fate choice, we have
not yet fully addressed whether the same model applies equally
well to other Th cell subsets such as Th17 cells or inducible reg-
ulatory T (iTreg) cells. However, there are also clear indications
in the literature that strength of TCR signaling influences differ-
entiation along these pathways as well (Fazilleau et al., 2009;
Gottschalk et al., 2010). What remains to be determined is
the overall scaling of signal input with fate determination for
the entire range of Th cell subsets, the relationship of signal
strength to induction of other cytokine receptors besides IL-
12Rb2, how polarizing adjuvants or PAMPs contribute to mod-
ulation of antigen-specific signaling through other costimulatory
molecules as we report here for CD80 and CD86, and whether
there are conditions in which cytokines or metabolites (Arpaia
et al., 2013; Furusawa et al., 2013) achieve dominance over
the antigen-associated signals. A last point involves under-
standing how the diversity of TCR affinities and the variation
in the amount of antigen presented (self or foreign) shape theoverall quality of the emerging response under infectious or
steady-state conditions.
A particularly relevant question is how there could be a consis-
tent difference in antigen stimulation strength between helminth
infections (which typically promote Th2 cell responses) and bac-
terial, viral, or unicellular parasitic infections (which often pro-
mote Th1 cell responses) (Finkelman et al., 2004; Zhu et al.,
2010). It is unlikely that the affinity of the TCRs recognizing pep-
tide ligands derived from the two different classes of pathogens
(Th1-cell-inducing versus Th2-cell-inducing) is on average
different. However, as cited above for the gastritis model (Levin
et al., 2008) and shown here via a reductionist system, variation
in the amount of pMHC ligand displayed on a DC in concert with
the extent of CD80 and CD86 expression can have dramatic ef-
fects on T cell effector choice. In the case of worms, they are too
large to be phagocytized and they do not reside in intracellular
compartments, whereas the Th1-cell-inducing pathogens can
be taken up and often require intracellular residence. There is
thus a high likelihood of extensive antigen delivery directly to pre-
senting cells in the latter case, whereas for extracellular worms,
only smaller amounts of antigen can access the presentation
pathway through shed material acquired via endocytic uptake.
When this is combinedwith evolution of theworms to limit detec-
tion by sensors controlling the DC activation pathways that pro-
mote maturation of the antigen processing machinery (Inaba
et al., 2000) and upregulation of CD80 and CD86 (Lee and Kim,
2007), it becomes understandable how a broad parsing of the
strength of T cell stimulation can occur for these different types
of infectious agents and why the immune system would have
evolved to link development of the necessary class of CD4+
T cell effector response to such differences in the T cell stimula-
tory environment.
Many biological systems use differences in the magnitude
or duration of signaling to control the qualitative state of the
cell (Chen et al., 2001; Purvis and Lahav, 2013). Here we show
that the immune system employs a cascading checkpoint
mechanism to translate quantitative differences in early antigen
and costimulatory T cell signaling into qualitative regulation of
CD4+ effector T cell differentiation by the cytokines whose role
in this process is so well recognized. These findings have impor-
tant implications for vaccine design in terms of how adjuvants
actually mediate their effects and how the balance of antigen
amount and choice of adjuvant affect the direct and indirect roles
of CD4+ cells in mediating postvaccination host defense. They
also may provide insight into the dominance of different states
of adaptive immune polarity during autoimmune processes.EXPERIMENTAL PROCEDURES
Mice
B10.A CD45.2, B10.A CD45.2+ 5CC7 TCR-transgenic Rag2/, and B10.A
CD45.2+ 5CC7 TCR-transgenic Rag2/ Il4G4/G4 (Hu-Li et al., 2001) 3 Ifng/
mice were obtained from Taconic Laboratories through a special NIAID con-
tract. All mice were maintained in SPF conditions at an Association for Assess-
ment andAccreditation of Laboratory AnimalCare-accredited animal facility. All
procedureswere approvedby theNIAIDAnimalCare andUseCommittee (NIH).
Peptides
Pigeon cytochrome C (pPCC): KAERADLIAYLKQATAK was from Amer-
ican Peptide Company and long chain biotinylated pigeon cytochromeImmunity 41, 63–74, July 17, 2014 ª2014 Elsevier Inc. 71
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Scientific.
Adoptive Cell Transfer
CD11c+ DCs were purified by positive immunomagnetic cell sorting for CD11c
(Miltenyi Biotec) as described in product literature from spleens of B10.A
CD45.2 donor mice. Polyclonal CD4+ T cells from LNs of B10.A CD45.2
and from TCR transgenic 5CC7 B10.A CD45.2+mice were purified by negative
immunomagnetic cell sorting (Miltenyi Biotec). DCs were incubated in vitro in
cRPMI (RPMI 1640 supplemented with 10% FCS, 2-ME, glutamine, penicillin,
streptomycin, and sodium pyruvate [Lonza]) with the adjuvants LPS (1.0 mg/ml,
Invivogen), papain (100 mg/ml, Calbiochem), CpG (25 mg/ml, Invivogen), or SEA
(40 mg/ml) for 4 hr at 37C in the presence of various concentrations of peptide
as indicated. CD11c+ DCs were transferred by s.c. injection into the right rear
footpad at 13 106/recipient, and CD4+ T cells were transferred by i.v. injection
at 2 3 106/recipient at 18 hr posttransfer of CD11c+ DCs. Where indicated
mice were injected i.v. with 100 mg anti-CD62L blocking antibody (MEL-14)
at 2 hr after CD4+ T cell transfer. For CD80 blockade studies, mice were in-
jected with either 200 mg anti-CD80 blocking Ab (16.10A1) or 200 mg isotype
control Ab (eBio299Arm) 30 min prior to CD4+ T cell transfer.
Ex Vivo CD4+ T Cell Restimulation
At day 4 after CD4+ T cell transfer, intracellular cytokine production was deter-
mined after preparation of cell suspensions from dLNs. Cells were restimu-
lated in cRPMI with PMA (100 ng/ml, Sigma) and ionomycin (1 mg/ml, Sigma)
in the presence of monensin (2 mM, Sigma) at 37C for 4 hr. Cells were surface
stained with anti-CD4 (GK1.5, Biolegend) and anti-CD45.2 (104, Biolegend)
and live cell staining was performed with LIVE DEAD fixable violet dead cell
stain (Invitrogen). Cells were fixed and permeabilized with BD Cytofix Cyto-
perm kit (BD PharMingen) according to the manufacturer’s instructions. Intra-
cellular cytokine staining was performed with anti-IFN-g (XMG1.2, Biolegend)
and anti-IL-4 (11B11, Biolegend). Flow cytometric data were collected on an
LSR II (BD Biosciences) and analyzed with FlowJo software (TreeStar).
2P Intravital Imaging and Calcium Analysis
Isoflurane was used to anesthetize mice prior to exposure of popliteal LN
(Baxter; 2.5% for induction, 1%–1.5% for maintenance, vaporized in an
80:20 mixture of O2 and air), and subsequent 2P-IVMwas performed via a pro-
tocol modified from a previous report (Baje´noff et al., 2006). Imaging was
conducted on either (1) a Bio-Rad/Zeiss Radiance 2100MP equipped with
a Chameleon laser (Coherent) tuned to 800 nm, configured with a Nikon
600FN upright microscope equipped with a 203 water immersion lens (NA
0.95, Olympus) and using LaserSharp acquisition control software or (2) a
Zeiss 710 microscope equipped with a Chameleon laser (Coherent) tuned to
800 nm in combination with a 203 water-dipping lens (NA 1.0, Zeiss) using
Zen 2010 acquisition software. Imaging was conducted in enclosed environ-
mental chambers in which anesthetized mice were warmed by heated air
and the surgically exposed LN was kept at 36C–37C with warmed PBS.
To visualize cells, CD11c+ DCs were labeled with either 100 mM CTB
(7-amino-4-chloromethylcoumarin, Invitrogen) or 1.25 mM CMFDA (5-chloro-
methylfluorescein diacetate, Invitrogen) for 20 min at 37C in Hanks buffered
salt solution (HBSS). CD4+ T cells were stained with either 1.25 mM CMFDA
or 1.25 mM CMTPX (Invitrogen) for 20 min at 37C in HBSS. For Ca2+ flux
assessment, cells were costained with 1.25 mM CMTPX and 2.5 mM Fluor-4
(Invitrogen) for 20 min at 37C in HBSS. After staining with CMTPX, cells
were further incubated in cRPMI for 30 min at 37C. All dyes were supplied
byMolecular Probes. Calcium flux analysis was conducted in a relative fashion
by determining the basal ratio of Fluor-4:CMTPX intensity for individual cells
after tracking with Imaris Imageworks. At subsequent time points, the ratio
of Fluor-4 intensity to CMTPX intensity was determined and related to the
basal ratio to determine the relative amount of calcium flux present in specific
cells. This method was internally validated in each experiment by analysis of
CD4+ T cells not interacting with DCs, where the ratio of Fluor-4:CMTPX had
a mean of 1.0.
Static two-photon imaging was conducted after PFA fixation of whole LNs,
which were subsequently frozen in OCT compound (Tissue Tek) and serially
sectioned into 100 mm sections. CD4+ T cell-DC interfaces were calculated
after the digital reconstruction of whole LNs by Imaris Imageworks. Channel-72 Immunity 41, 63–74, July 17, 2014 ª2014 Elsevier Inc.specific 3D objects were generated and a pixel colocalization gating strategy
was employed to determine the specific voxel size of cell-to-cell interactions.
Analysis of Peptide-Loaded, Adjuvant-Treated DCs
CD11c+ DCs were prepared as above for adoptive cell transfer in the presence
of adjuvant with either 0.1 mm pPCC or 10.0 mm LC-pPCC as indicated. DCs
were then either analyzed immediately by flow cytometry for in vitro analysis
or adoptively transferred into the footpad and recovered at 24 hr posttransfer
for ex vivo analysis. The DC phenotype was determined after staining with
MHCII (M5/114.15.2), CD80 (16-10A1), CD86 (GL-1), ICAM-1 (YN1/1.7.4),
and ICOSL (HK5.3). LC-pPCC binding was analyzed after staining with Strep-
tavidin-PE (BD PharMingen) or Streptavidin-Qdot 605 (Invitrogen), as per
Huang et al. (2013). ELISA was conducted for the detection of IL-12p70
(Biolegend, ELISA Max Delux), and Cytometric Bead Array (BD, Multiplexed
Bead Array) was conducted for the detection of IL-6 and IL-12 production at
4 hr or 24 hr poststimulation in the presence or absence of pPCC or LPS as
per the manufacturer’s instructions. Flow cytometry was conducted on an
LSRII (BD) and analyzed with FlowJo software (Tree Star).
CD4+ T Cell Activation Analysis
WT or Il4G4/G4Ifng/ 5CC7 CD4+ T cells were activated by in vitro culture in
cRPMI with P13.9 fibroblasts stably expressing MHCII, CD80, and ICAM-1
(Ding et al., 1993) that had previously been treated with 25 mg/ml mitomycin
C, in the presence of 0.005–10.0 mM pPCC. Alternately, WT 5CC7 CD4+
T cells were activated in vivo with CD11c+ DCs treated with either LPS or
papain in the presence of 0.1 mM pPCC (as per adoptive cell transfer method-
ology). After activation for 0–24 hr as indicated, CD4+ T cells were harvested
and stained for CD4 (GK1.5), CD45.2 (104), CD69 (H1.2F3), IL-12Rb2 (114),
and IL-4R (mIL4R-M1). Flow cytometry was conducted on an LSRII (BD) and
analyzed with FlowJo software (Tree Star).
Statistical Methods
One-way ANOVA with Tukey’s posttesting were used for the statistical anal-
ysis of multiple groups. Student’s t test (two-tailed) were used for the statistical
analysis of differences between two groups.
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